US

Uday Shankar Singh

Active Director Managing Director DIN 10752840
DIN 10752840 First appointment Aug 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Uday Shankar Singh

Data last updated:

Uday Shankar Singh is a Managing Director at Medixen Pharma Private Limited (since 2024). Medixen Pharma Private Limited reported revenue of ₹29,024 (FY 2025).

DIN 10752840
Primary Designation Managing Director
First Appointment 24 Aug 2024
Oldest Company Age 2 yrs
Largest company Medixen Pharma Private Limited · ₹29,024 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medixen Pharma Private Limited U46497DL2024PTC435829
Managing Director24 Aug 20242024₹29,024 (FY 2025)Active

Board colleagues of Uday Shankar Singh

NameDINCompanyDesignation
Prabha Singh07566491Medixen Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medixen Pharma Private Limited
Premium access

Shareholding and investment profile for Uday Shankar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uday Shankar Singh

Uday Shankar Singh currently holds 1 directorship: Medixen Pharma Private Limited (Managing Director, since 24 Aug 2024, revenue ₹29,024 (FY 2025)).

Uday Shankar Singh was first appointed on 24 Aug 2024 as Managing Director at Medixen Pharma Private Limited.

The current boards of Uday Shankar Singh's companies include Prabha Singh (Medixen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available